X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PANACEA BIOTECH - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PANACEA BIOTECH J.B.CHEMICALS/
PANACEA BIOTECH
 
P/E (TTM) x 17.1 -6.2 - View Chart
P/BV x 2.3 1.9 125.3% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   PANACEA BIOTECH
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
PANACEA BIOTECH
Mar-14
J.B.CHEMICALS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs318149 213.9%   
Low Rs20082 242.4%   
Sales per share (Unadj.) Rs148.084.1 175.9%  
Earnings per share (Unadj.) Rs19.1-18.3 -104.2%  
Cash flow per share (Unadj.) Rs23.9-6.7 -357.5%  
Dividends per share (Unadj.) Rs0.500-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs128.983.7 154.0%  
Shares outstanding (eoy) m84.8261.25 138.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.4 127.4%   
Avg P/E ratio x13.6-6.3 -214.9%  
P/CF ratio (eoy) x10.8-17.2 -62.7%  
Price / Book Value ratio x2.01.4 145.5%  
Dividend payout %2.60-   
Avg Mkt Cap Rs m21,9517,074 310.3%   
No. of employees `0002.72.8 99.4%   
Total wages/salary Rs m1,8411,449 127.0%   
Avg. sales/employee Rs Th4,590.91,874.1 245.0%   
Avg. wages/employee Rs Th673.4527.0 127.8%   
Avg. net profit/employee Rs Th592.1-407.7 -145.2%   
INCOME DATA
Net Sales Rs m12,5515,154 243.5%  
Other income Rs m542100 542.7%   
Total revenues Rs m13,0935,254 249.2%   
Gross profit Rs m2,055-766 -268.1%  
Depreciation Rs m412711 58.0%   
Interest Rs m961,503 6.4%   
Profit before tax Rs m2,088-2,881 -72.5%   
Minority Interest Rs m011 -3.7%   
Prior Period Items Rs m0-6 0.0%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m46917 2,792.2%   
Profit after tax Rs m1,619-1,121 -144.4%  
Gross profit margin %16.4-14.9 -110.1%  
Effective tax rate %22.5-0.6 -3,851.6%   
Net profit margin %12.9-21.8 -59.3%  
BALANCE SHEET DATA
Current assets Rs m7,7783,810 204.1%   
Current liabilities Rs m4,3588,365 52.1%   
Net working cap to sales %27.2-88.4 -30.8%  
Current ratio x1.80.5 391.8%  
Inventory Days Days55156 35.1%  
Debtors Days Days8067 119.0%  
Net fixed assets Rs m5,71314,480 39.5%   
Share capital Rs m17061 276.7%   
"Free" reserves Rs m10,547903 1,167.8%   
Net worth Rs m10,9375,127 213.3%   
Long term debt Rs m05,832 0.0%   
Total assets Rs m15,57419,433 80.1%  
Interest coverage x22.8-0.9 -2,489.9%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.80.3 303.9%   
Return on assets %11.02.0 560.5%  
Return on equity %14.8-21.9 -67.7%  
Return on capital %20.03.6 549.0%  
Exports to sales %48.724.5 198.7%   
Imports to sales %7.110.2 69.5%   
Exports (fob) Rs m6,1151,264 483.9%   
Imports (cif) Rs m889525 169.3%   
Fx inflow Rs m6,1691,539 400.8%   
Fx outflow Rs m1,285942 136.4%   
Net fx Rs m4,884597 817.8%   
CASH FLOW
From Operations Rs m1,397599 233.1%  
From Investments Rs m-320-438 73.1%  
From Financial Activity Rs m-1,196-303 395.2%  
Net Cashflow Rs m-102-141 72.4%  

Share Holding

Indian Promoters % 55.4 74.5 74.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.6 565.0%  
FIIs % 3.9 1.3 300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 23.6 156.8%  
Shareholders   30,437 10,259 296.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   STERLING BIOTECH  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  NOVARTIS  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks ahead of Election Results; Realty Stocks Plummet(Closing)

Indian share markets settled around 2% lower today following a sell-off in the global markets and due to uncertainty over the outcome of state assembly elections tomorrow.

Related Views on News

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (4QFY18); Net Profit Down 66.5% (Quarterly Result Update)

Jun 20, 2018 | Updated on Jun 20, 2018

For the quarter ended March 2018, PANACEA BIOTECH has posted a net profit of Rs 86 m (down 66.5% YoY). Sales on the other hand came in at Rs 2 bn (up 0.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Dec 10, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - PFIZER COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS